Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion

Journal of Cell Science

Volumn 125, Issue 19, 2012, Pages 4475-4486

  Gaudineau, Benoît ^a   Fougère, Marjorie ^a   Guaddachi, Frédéric ^a   Lemoine, Frédéric ^b   de la Grange, Pierre ^b   Jauliac, Sébastien ^a  

^a CNRS   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

LCN2; Motility; NFAT1; TWEAK; TWEAKR

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NFAT1 PROTEIN; RNA; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR RECEPTOR; TWEAKER PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL INVASION; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

ACUTE-PHASE PROTEINS; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; LIPOCALINS; MICE; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NFATC TRANSCRIPTION FACTORS; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 84872178773     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.099879     Document Type: Article

References (58)

1. Albini, A. and Benelli, R. (2007). The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat. Protoc. 2, 504-511.
2. Baksh, S., Widlund, H. R., Frazer-Abel, A. A., Du, J., Fosmire, S., Fisher, D. E., DeCaprio, J. A., Modiano, J. F. and Burakoff, S. J. (2002). NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol. Cell 10, 1071-1081.
3. Balkwill, F. and Mantovani, A. (2001). Inflammation and cancer: back to Virchow? Lancet 357, 539-545.
4. Bartsch, S. and Tschesche, H. (1995). Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett. 357, 255-259.
5. Buchholz, M., Schatz, A., Wagner, M., Michl, P., Linhart, T., Adler, G., Gress, T. M. and Ellenrieder, V. (2006). Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J. 25, 3714-3724.
6. Chen, M. and O'Connor, K. L. (2005). Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. Oncogene 24, 5125-5130.
7. Chuvpilo, S., Jankevics, E., Tyrsin, D., Akimzhanov, A., Moroz, D., Jha, M. K., Schulze-Luehrmann, J., Santner-Nanan, B., Feoktistova, E., König, T. et al. (2002). Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16, 881-895.
8. Culp, P. A., Choi, D., Zhang, Y., Yin, J., Seto, P., Ybarra, S. E., Su, M., Sho, M., Steinle, R., Wong, M. H. et al. (2010). Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms. Clin. Cancer Res. 16, 497-508.
9. Dai, L., Gu, L., Ding, C., Qiu, L. and Di, W. (2009). TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression. Cancer Lett. 283, 159-167.
10. Dejmek, J., Säfholm, A., Kamp Nielsen, C., Andersson, T. and Leandersson, K. (2006). Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells. Mol. Cell. Biol. 26, 6024-6036.
11. Flower, D. R. (1996). The lipocalin protein family: structure and function. Biochem. J. 318, 1-14.
12. Foldynová-Trantírková, S., Sekyrová, P., Tmejová, K., Brumovská, E., Bernatík, O., Blankenfeldt, W., Krejcí, P., Kozubík, A., Dolezal, T., Trantírek, L. et al. (2010). Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Res. 12, R30.
13. Fougère, M., Gaudineau, B., Barbier, J., Guaddachi, F., Feugeas, J. P., Auboeuf, D. and Jauliac, S. (2010). NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene. Oncogene 29, 2292-2301.
14. Friedl, P. and Wolf, K. (2003). Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem. Soc. Symp. 70, 277-285.
15. Furutani, M., Arii, S., Mizumoto, M., Kato, M. and Imamura, M. (1998). Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett. 122, 209-214.
16. Germann, S., Gratadou, L., Zonta, E., Dardenne, E., Gaudineau, B., Fougère, M., Samaan, S., Dutertre, M., Jauliac, S. and Auboeuf, D. (2012). Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor. Oncogene 31, 4536-4549.
17. Glud, S. Z., Sørensen, A. B., Andrulis, M., Wang, B., Kondo, E., Jessen, R., Krenacs, L., Stelkovics, E., Wabl, M., Serfling, E. et al. (2005). A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 106, 3546-3552.
18. Graef, I. A., Chen, F., Chen, L., Kuo, A. and Crabtree, G. R. (2001). Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105, 863-875.
19. Gwira, J. A., Wei, F., Ishibe, S., Ueland, J. M., Barasch, J. and Cantley, L. G. (2005). Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J. Biol. Chem. 280, 7875-7882.
20. Hauck, C. R., Hsia, D. A., Puente, X. S., Cheresh, D. A. and Schlaepfer, D. D. (2002). FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J. 21, 6289-6302.
21. Holzmann, K., Kohlhammer, H., Schwaenen, C., Wessendorf, S., Kestler, H. A., Schwoerer, A., Rau, B., Radlwimmer, B., Döhner, H., Lichter, P. et al. (2004). Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res. 64, 4428-4433.
22. Hsia, D. A., Mitra, S. K., Hauck, C. R., Streblow, D. N., Nelson, J. A., Ilic, D., Huang, S., Li, E., Nemerow, G. R., Leng, J. et al. (2003). Differential regulation of cell motility and invasion by FAK. J. Cell Biol. 160, 753-767.
23. Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y. et al. (2008). Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13, 394-406.
24. Iliopoulos, D., Hirsch, H. A. and Struhl, K. (2009). An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706.
25. Irie, H. Y., Pearline, R. V., Grueneberg, D., Hsia, M., Ravichandran, P., Kothari, N., Natesan, S. and Brugge, J. S. (2005). Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171, 1023-1034.
26. Jauliac, S., López-Rodriguez, C., Shaw, L. M., Brown, L. F., Rao, A. and Toker, A. (2002). The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat. Cell Biol. 4, 540-544.
27. Jönsson, M., Dejmek, J., Bendahl, P. O. and Andersson, T. (2002). Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res. 62, 409-416.
28. Kaduka, Y., Takeda, K., Nakayama, M., Kinoshita, K., Yagita, H. and Okumura, K. (2005). TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage. Biochem. Biophys. Res. Commun. 331, 384-390.
29. Krueger, J. S., Keshamouni, V. G., Atanaskova, N. and Reddy, K. B. (2001). Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion. Oncogene 20, 4209-4218.
30. Lee, H., Chouinard, L., Bonin, M. and Michel, R. N. (2005). NFATc3 deficiency may contribute to the development of mammary gland adenocarcinoma in aging female mice. Mol. Carcinog. 44, 219-222.
31. Leng, X., Lin, H., Ding, T., Wang, Y., Wu, Y., Klumpp, S., Sun, T., Zhou, Y., Monaco, P., Belmont, J. et al. (2008). Lipocalin 2 is required for BCR-ABLinduced tumorigenesis. Oncogene 27, 6110-6119.
32. Lopez-Rodríguez, C., Aramburu, J., Rakeman, A. S. and Rao, A. (1999). NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl. Acad. Sci. USA 96, 7214-7219.
33. Maecker, H., Varfolomeev, E., Kischkel, F., Lawrence, D., LeBlanc, H., Lee, W., Hurst, S., Danilenko, D., Li, J., Filvaroff, E. et al. (2005). TWEAK attenuates the transition from innate to adaptive immunity. Cell 123, 931-944.
34. Mancini, M. and Toker, A. (2009). NFAT proteins: emerging roles in cancer progression. Nat. Rev. Cancer 9, 810-820.
35. Meighan-Mantha, R. L., Hsu, D. K., Guo, Y., Brown, S. A., Feng, S. L., Peifley, K. A., Alberts, G. F., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. et al. (1999). The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 274, 33166-33176.
36. Michaelson, J. S., Cho, S., Browning, B., Zheng, T. S., Lincecum, J. M., Wang, M. Z., Hsu, Y. M. and Burkly, L. C. (2005). Tweak induces mammary epithelial branching morphogenesis. Oncogene 24, 2613-2624.
37. Missiaglia, E., Blaveri, E., Terris, B., Wang, Y. H., Costello, E., Neoptolemos, J. P., Crnogorac-Jurcevic, T. and Lemoine, N. R. (2004). Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int. J. Cancer 112, 100-112.
38. Neal, J. W. and Clipstone, N. A. (2003). A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J. Biol. Chem. 278, 17246-17254.
39. Nielsen, B. S., Borregaard, N., Bundgaard, J. R., Timshel, S., Sehested, M. and Kjeldsen, L. (1996). Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38, 414-420.
40. Peternel, S., Manestar-Blažić, T., Brajac, I., Prpić-Massari, L. and Kaštelan, M. (2011). Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes. J. Cutan. Pathol. 38, 780-789.
41. Pierce, B. L., Ballard-Barbash, R., Bernstein, L., Baumgartner, R. N., Neuhouser, M. L., Wener, M. H., Baumgartner, K. B., Gilliland, F. D., Sorensen, B. E., McTiernan, A. et al. (2009). Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J. Clin. Oncol. 27, 3437-3444.
42. Playford, R. J., Belo, A., Poulsom, R., Fitzgerald, A. J., Harris, K., Pawluczyk, I., Ryon, J., Darby, T., Nilsen-Hamilton, M., Ghosh, S. et al. (2006). Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 131, 809-817.
43. Polek, T. C., Talpaz, M., Darnay, B. G. and Spivak-Kroizman, T. (2003). TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor. J. Biol. Chem. 278, 32317-32323.
44. Ranger, A. M., Oukka, M., Rengarajan, J. and Glimcher, L. H. (1998). Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9, 627-635.
45. Robbs, B. K., Cruz, A. L. S., Werneck, M. B. F., Mognol, G. P. and Viola, J. P. B. (2008). Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol. Cell. Biol. 28, 7168-7181.
46. Shaw, J. P., Utz, P. J., Durand, D. B., Toole, J. J., Emmel, E. A. and Crabtree, G. R. (1988). Identification of a putative regulator of early T cell activation genes. Science 241, 202-205.
47. Shi, H., Gu, Y., Yang, J., Xu, L., Mi, W. and Yu, W. (2008). Lipocalin 2 promotes lung metastasis of murine breast cancer cells. J. Exp. Clin. Cancer Res. 27, 83.
48. Stoesz, S. P., Friedl, A., Haag, J. D., Lindstrom, M. J., Clark, G. M. and Gould, M. N. (1998). Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int. J. Cancer 79, 565-572.
49. Tran, N. L., McDonough, W. S., Savitch, B. A., Fortin, S. P., Winkles, J. A., Symons, M., Nakada, M., Cunliffe, H. E., Hostetter, G., Hoelzinger, D. B. et al. (2006). Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome. Cancer Res. 66, 9535-9542.
50. Vincent, C., Findlay, D. M., Welldon, K. J., Wijenayaka, A. R., Zheng, T. S., Haynes, D. R., Fazzalari, N. L., Evdokiou, A. and Atkins, G. J. (2009). Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J. Bone Miner. Res. 24, 1434-1449.
51. Wiley, S. R., Cassiano, L., Lofton, T., Davis-Smith, T., Winkles, J. A., Lindner, V., Liu, H., Daniel, T. O., Smith, C. A. and Fanslow, W. C. (2001). A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15, 837-846.
52. Willis, A. L., Tran, N. L., Chatigny, J. M., Charlton, N., Vu, H., Brown, S. A., Black, M. A., McDonough, W. S., Fortin, S. P., Niska, J. R. et al. (2008). The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity. Mol. Cancer Res. 6, 725-734.
53. Winkles, J. A. (2008). The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat. Rev. Drug Discov. 7, 411-425.
54. Wu, X., Nguyen, B. C., Dziunycz, P., Chang, S., Brooks, Y., Lefort, K., Hofbauer, G. F. and Dotto, G. P. (2010). Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465, 368-372.
55. Xanthoudakis, S., Viola, J. P., Shaw, K. T., Luo, C., Wallace, J. D., Bozza, P. T., Luk, D. C., Curran, T. and Rao, A. (1996). An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272, 892-895.
56. Yang, J., Bielenberg, D. R., Rodig, S. J., Doiron, R., Clifton, M. C., Kung, A. L., Strong, R. K., Zurakowski, D. and Moses, M. A. (2009). Lipocalin 2 promotes breast cancer progression. Proc. Natl. Acad. Sci. USA 106, 3913-3918.
57. Yiu, G. K. and Toker, A. (2006). NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J. Biol. Chem. 281, 12210-12217.
58. Yoeli-Lerner, M., Yiu, G. K., Rabinovitz, I., Erhardt, P., Jauliac, S. and Toker, A. (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20, 539-550.